Therapeutic Strategies
Therapeutic strategies for NAFLD are manually extracted from research articles. For each strategy, reference researches are provided, and related therapeutic targets, drugs and repositioning candidates in NAFLDkb are presented with knowledge graphs.
timeline
17 records.
| Strategy ID | Strategy | Other Terms | Related Targets | Related Drugs | |
|---|---|---|---|---|---|
| S11 | Anti-hypertensive | -- | angiotensin converting enzyme inhibitors (ACEi) ; angiotensin II receptor blockers (ARBs) | Captopril | Details |
| S12 | Anti-platelet aggregation | -- | Platelet GPIbα | aspirin/clopidogrel; ticagrelor | Details |
| S13 | Anti-apoptosis | hepatocyte apoptosis; hepatic autophagy; apoptosis | Pan-caspase inhibitor | Emricasan | Details |
| S14 | Digital therapeutics | Internet-based approach; Web-Based Exercise; Mobile Technology; Mobile APP | -- | -- | Details |
| S15 | Cell therapy | Mesenchymal stem cells; Stem cell therapy | -- | -- | Details |
| S16 | Immunotherapy | -- | -- | -- | Details |
| S17 | Genetic therapy | Genetic approaches; genetherapy; Gene therapy | HSD17B13 inhibitor; PNPLA3-rs7 38409 (I148M) variant inhibitor; PNPLA3 expression down-regulator | INI-678; Momelotinib | Details |